Does POMALIDOMIDE Cause Basal cell carcinoma? 93 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 93 reports of Basal cell carcinoma have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.1% of all adverse event reports for POMALIDOMIDE.
93
Reports of Basal cell carcinoma with POMALIDOMIDE
0.1%
of all POMALIDOMIDE reports
1
Deaths
14
Hospitalizations
How Dangerous Is Basal cell carcinoma From POMALIDOMIDE?
Of the 93 reports, 1 (1.1%) resulted in death, 14 (15.1%) required hospitalization, and 2 (2.2%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for POMALIDOMIDE.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which POMALIDOMIDE Alternatives Have Lower Basal cell carcinoma Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA